• home
  • leadership
    mentors and mavens
  • innovation
  • billionaires
  • startups
  • AI Tracker
  • Lists
    India Rich List 2025AI Special 2025W Power 202530 Under 30 2025India Rich List 2024Digital Stars 2024All Lists
  • Podcasts
    To The PointTech ConversationsMoney TalksStartup FridaysFrom the BookshelvesAll Podcasts
  • Videos
    Leadership MantrasPathbreakersLets Talk AboutOne Thing Today in TechMomentumNuts and BoltsIn Conversation WithFrom the FieldBeyond the BoardroomAll Videos
  • Magazine
  • More
    NewsLifeThought LeadershipBlogs

glaxosmithkline

Advertisement
Forbes List Logo
GlaxoSmithKline takes its medicines: How Andrew Witty patched up the sick drugmaker
Andrew Witty inherited a drugmaker sick with scandal and spent the next eight years patching up his patient. GlaxoSmithKline may finally be well again
ByMatthew Herper
Titans of the North
BySourav Majumdar
GSK Pharma's Billion-Dollar Buyback
BySamar Srivastava,Salil Panchal
A Shot of India: The Vaccine Market
BySeema Singh
  • Home
  • /
  • Glaxosmithkline
Subscribe Now
Advertisement
Advertisement
Advertisement

Latest News

  • UAE's Emirates NBD bets big on RBL Bank
  • Explainer: Inside Elon Musk’s $1 trillion equity pay package
  • Most Gen AI players remain 'far away' from profiting: Interview with Andy Wu
  • AI: Who will teach the teachers?